| |
| |
|
| Insider
Information: |
Ignelzi Troy A. |
| Relationship: |
|
| City: |
Plymouth |
| State: |
MI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
30,487 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
30,487 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Scpharmaceuticals Inc. |
SCPH |
|
|
0 |
|
0 |
Premium* |
|
|
Karuna Therapeutics, Inc. |
KRTX |
|
2023-08-22 |
30,487 |
2020-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-05-10 |
4 |
OE |
$9.20 |
$64,400 |
D/D |
7,000 |
20,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-05-12 |
4 |
OE |
$9.20 |
$1,840 |
D/D |
200 |
13,200 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-05-12 |
4 |
AS |
$120.00 |
$24,000 |
D/D |
(200) |
13,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-08-20 |
4 |
OE |
$9.20 |
$46,000 |
D/D |
5,000 |
18,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-08 |
4 |
OE |
$9.20 |
$69,920 |
D/D |
7,600 |
18,600 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-08 |
4 |
AS |
$116.16 |
$885,726 |
D/D |
(7,600) |
18,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-09 |
4 |
AS |
$120.05 |
$60,025 |
D/D |
(500) |
18,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-09 |
4 |
OE |
$9.20 |
$4,600 |
D/D |
500 |
18,500 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-10 |
4 |
OE |
$9.20 |
$17,480 |
D/D |
1,900 |
19,900 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-10 |
4 |
AS |
$120.05 |
$228,095 |
D/D |
(1,900) |
18,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-11-08 |
4 |
OE |
$9.20 |
$124,200 |
D/D |
13,500 |
31,500 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-11-08 |
4 |
AS |
$152.32 |
$2,056,320 |
D/D |
(13,500) |
18,000 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-12-21 |
4 |
OE |
$9.20 |
$64,124 |
D/D |
6,970 |
24,970 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-02-15 |
4 |
OE |
$9.20 |
$13,800 |
D/D |
1,500 |
26,470 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-02-15 |
4 |
AS |
$111.14 |
$166,710 |
D/D |
(1,500) |
24,970 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-04-19 |
4 |
AS |
$130.81 |
$457,835 |
D/D |
(3,500) |
24,970 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-04-19 |
4 |
OE |
$9.20 |
$32,200 |
D/D |
3,500 |
28,470 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-04-20 |
4 |
OE |
$9.20 |
$6,477 |
D/D |
704 |
25,674 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-04-20 |
4 |
AS |
$133.20 |
$93,773 |
D/D |
(704) |
24,970 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-04-21 |
4 |
OE |
$9.20 |
$368 |
D/D |
40 |
25,010 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-04-21 |
4 |
AS |
$134.46 |
$5,378 |
D/D |
(40) |
24,970 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-08-09 |
4 |
OE |
$9.20 |
$151,800 |
D/D |
16,500 |
41,470 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-08-09 |
4 |
AS |
$227.83 |
$3,759,195 |
D/D |
(16,500) |
24,970 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-09-30 |
4 |
S |
$227.05 |
$2,403,017 |
D/D |
(10,500) |
14,470 |
0 |
- |
|
| KRTX |
Karuna Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-10-03 |
4 |
S |
$230.02 |
$947,820 |
D/D |
(4,100) |
10,370 |
0 |
- |
|
65 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
